Patient-Reported Outcome-Based Symptom Management Versus Usual Care After Lung Cancer Surgery: A Multicenter Randomized Controlled Trial.

Wei DaiWenhong FengYuanqiang ZhangXin Shelley Wang Yangjun Liu Cecilia PompiliWei XuShaohua XieYaqin WangJia LiaoXing WeiRun XiangBin HuBo TianXiaozun YangXiang WangPing XiaoQi LaiXin Wang Bangrong Cao Qifeng WangFang LiuXiaoqin LiuTianpeng XieXiaojun YangXiang ZhuangZhong WuGuowei CheQiang LiQiuling Shi

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)

PRO-based symptom management after lung cancer surgery showed lower symptom burden and fewer complications than usual care for up to 4 weeks postdischarge.

Keyphrases

minimally invasive
randomized controlled trial
patient reported outcomes
coronary artery bypass
healthcare
palliative care
quality improvement
patient reported
risk factors
surgical site infection
study protocol
pain management
affordable care act
cross sectional
coronary artery disease